Update
$Sellas Life Sciences (SLS.US)$ Reuters· 5 mins ago
Sellas Receives EMA Orphan Drug Designation for Sls009 for Treatment of Peripheral T-Cell Lymphomas
Sellas Receives EMA Orphan Drug Designation for Sls009 for Treatment of Peripheral T-Cell Lymphomas
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
NercZ24 : is this a good thing?
Trytosaveabit OP NercZ24 : It is a good thing! But it’s only phase 1 so waiting to see how market reacts?
NercZ24 : ahhh